I am confused.
My urologist recommends Provenge given my low cancer burden and that I am asymptomatic after RP, Taxane chemo, and two rounds of EBRT, all with Eligard every 3 months. Current PSA is 0.6 with a doubling time of 3 months. I am now castrate resistant.
My research MO says forget Provenge, it’s efficacy is questionable. Consider a clinical trial involving abiraterone plus “X.” But this means waiting until PSA hits 2.0 for most clinical trials.
Why should I wait until PSA is >2.0? We know I am now castrate resistant. And why not Provenge? It has been shown to prolong life >1 year for men with PSA<20.
Maybe I could have an even better result with a PSA <1.0.